The US Food and Drug Administration is considering limiting future Covid-19 vaccine approvals, to adults aged 65 and older, and those with underlying health conditions that increase their risk of ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

According to Makary and Prasad, the US’s adoption of a “one-size-fits-all” guidance for COVID-19 vaccination departs from ...

In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only to people over 65 years old or those with an underlying health condition.

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

A lot of 2024 retrospectives have been based on vibes. Now we have some really good data. Here’s what it says.

Revised FDA guidelines also require placebo testing on updated covid vaccines. The new plan has pediatricians concerned for young ones in their care, but one MAHA influencer says the new rules aren't ...